Investigating how microRNA affects nerve protection to reduce pain from chemotherapy and Alzheimer's.
microRNA regulation of NMNAT-mediated Neuroprotection against Peripheral Neuropathy and Chronic Pain
This study is looking at how a tiny molecule and a specific protein might help protect nerves from damage caused by chemotherapy and Alzheimer's, using fruit fly larvae to learn more about nerve pain and find new ways to help people feel better.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Chicago NIH-funded |
| Lab location | 1 site (Chicago, United States) |
| Project ID | NIH-11135937 on NIH RePORTER |
What this research studies
This research explores the relationship between microRNA and a protein called NMNAT, which may help protect nerves from damage caused by chemotherapy and Alzheimer's-related conditions. By using a model organism, Drosophila larvae, the researchers aim to understand the mechanisms behind peripheral neuropathy and chronic pain. The study focuses on how these conditions are linked and seeks to identify potential treatments that could alleviate pain and improve quality of life for affected patients.
Who could benefit from this research
Good fit: Ideal candidates for this research include cancer patients experiencing neuropathic pain due to chemotherapy and individuals with Alzheimer's or related dementias.
Not a fit: Patients who do not have chemotherapy-induced peripheral neuropathy or Alzheimer's-related conditions may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments that reduce chronic pain and improve nerve health in patients suffering from chemotherapy-induced neuropathy and Alzheimer's-related dementia.
How similar studies have performed: Previous research has shown promising results in understanding the mechanisms of peripheral neuropathy and neuroprotection, suggesting that this approach could yield valuable insights.
Where this research is happening
Chicago, United States
- University of Chicago — Chicago, United States (Active)
Researchers
- Principal investigator: Zhai, Rong Grace — University of Chicago
- Study coordinator: Zhai, Rong Grace
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.